Elizabeth Ruth Plummer
Northern Institute for Cancer Research
University of Newcastle upon Tyne
Newcastle upon Tyne
United Kingdom
Name/email consistency: high
- Targeting poly(ADP-ribose) polymerase: a two-armed strategy for cancer therapy. Plummer, E.R., Calvert, H. Clin. Cancer Res. (2007)
- Inhibition of poly(ADP-ribose) polymerase in cancer. Plummer, E.R. Curr. Opin. Pharmacol (2006)
- Temozolomide pharmacodynamics in patients with metastatic melanoma: dna damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1. Plummer, E.R., Middleton, M.R., Jones, C., Olsen, A., Hickson, I., McHugh, P., Margison, G.P., McGown, G., Thorncroft, M., Watson, A.J., Boddy, A.V., Calvert, A.H., Harris, A.L., Newell, D.R., Curtin, N.J. Clin. Cancer Res. (2005)
- A phase I trial of ZD9331, a water-soluble, nonpolyglutamatable, thymidylate synthase inhibitor. Plummer, R., Rees, C., Hughes, A., Beale, P., Highley, M., Trigo, J., Gokul, S., Judson, I., Calvert, H., Jackman, A., Mitchell, F., Smith, R., Douglass, E. Clin. Cancer Res. (2003)